Navidea Biopharmaceuticals Inc (NAVB) Annual Balance Sheets

Annual · GAAP · USD millions
Access NAVB quarterly Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Navidea Biopharmaceuticals Inc adapts its asset base and funding mix.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2022)
(Dec 31 2021) (Dec 31 2020) (Dec 31 2019) (Dec 31 2018)
Assets
Cash & cash equivalent2.00
Available-for-sale Securities, Current MA0.00
Cash & Short-term Investments1.00
Accounts receivable0.00
Inventories0.43
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.78
Total Current Assets3.20
Equipment/Property/Plant Net0.14
Intangible Assets1.00
Other Assets, Noncurrent0.03
Total Assets4.37
Liabilities
Accounts Payable, Current AC2.12
Accrued Liabilities And Other Liabilities6.46
Notes Payable, Current NO0.54
Other Liabilities, Current0.00
Deferred Revenue, Current DE0.80
Total Current Liabilities9.94
Total Long-term Debt0.00
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent2.57
Terminated Lease Liability Current0.02
Terminated Lease Liability Noncurrent0.00
Total Liabilities12.51
Stockholders' Equity
Common Stock Value0.22
Common Stock, Held by Subsidiary etc.-
Additional Paid In Capital Common Stock379.34
Retained Earnings / Accumulated Deficit-388.00
Other Equity0.00
Common Stockholder's Equity-8.44
Preferred Stockholder's Equity0.00
Non-controlling interests & other0.29
Total Stockholder's Equity-8.14
Liabilities & Stockholder's Equity4.37
4 historic quarters locked

Sign in to unlock the full Navidea Biopharmaceuticals Inc balance sheet history.

About Navidea Biopharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001437749-23-032052

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.